(Bloomberg) -- Johnson & Johnson is withdrawing a device to treat debilitating acid reflux disease from markets outside the US, a move surgeons warned would set back the available treatment options ...

Johnson & Johnson (NYSE:JNJ) is one of the best conservative stocks to buy now. On September 23, the company announced plans to withdraw the LINX Reflux Management System in certain countries. The ...

LIMA — Dr. Jeremy Heffner, general surgeon at Lima Memorial Health System, has recently performed more than 100 LINX Reflux Management System procedures. According to a recent press release, Heffner’s ...

The FDA’s Gastroenterology-Urology Devices Panel voted unanimously that LINX’s Reflux Management System, a laparoscopically implanted device designed to treat gastroesophageal reflux disease, has a ...

Mayo Clinic in Jacksonville, Fla., has announced it will be one of the first healthcare organizations in the United States to offer the LINX Reflux Management System to treat gastroesophageal reflux ...

(Reuters) -Johnson & Johnson said on Tuesday it will withdraw a device to treat acid reflux disease from certain markets outside the United States, citing commercial reasons. The company has decided ...

One in five Americans suffers from gastroesophageal reflux disease (GERD), known colloquially as acid reflux. Acid reflux is a digestive disorder in in which acid backs up from the stomach into the ...